Vepafestinib [CAS 2129515-96-2]
Vepafestinib [CAS 2129515-96-2]
SKU:QM-0144182-01
Couldn't load pickup availability
Request quote or documents
![Vepafestinib [CAS 2129515-96-2]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
Vepafestinib (TAS0953/HM06) is a next-generation brain-penetrant, selective and orally active RET inhibitor with an IC50 value of 0.33 nM. Vepafestinib inhibits the phosphorylation of RET and its downstream signaling pathways, thus blocking the growth and signal transduction of tumor cells and inducing cell cycle arrest and apoptosis. Vepafestinib can be used in the research of various RET-driven cancers, such as non-small cell lung cancer, thyroid cancer and other disease areas[1].
-
CAS Number
[2129515-96-2]
-
Molecular Formula
C26H30N6O3
-
Molecular Weight
474.55
-
Smiles
O=C(C1=C(C#CCN2CCOCC2)N(C3(C)CC3)C4=NC=NC(N)=C41)NC5=CC=C(COC)C=C5
-
Target
Apoptosis; RET
-
Purity
98.61
-
Solubility
DMSO : 50 mg/mL (ultrasonic)
-
Storage Conditions
-20°C, 3 years (Powder)
-
Shipping Conditions
Blue Ice
Related Products
- QM-0155900-01 Telcagepant [CAS 781649-09-0]
- QM-0154745-01 Thio-TEPA [CAS 52-24-4]
- QM-0144531-01 β-Muricholic acid [CAS 2393-59-1]
- QM-0138030 Thromboxane B2-d9
- QM-0146071-01 Ursodeoxycholic acid [CAS 128-13-2]
- QM-0138107-01 Thromboxane B3 [CAS 71953-80-5]
- QM-0138131-01 Ursodeoxycholic acid-d4 [CAS 347841-46-7]
- QM-0138624 α-Muricholic acid-d5 [CAS 2725726-61-2]
- QM-0147689-01 Tauroursodeoxycholic acid-3-sulfate-d4 (sodium)
- QM-0081755-01 α-Galactosylceramide [CAS 158021-47-7]
Other industry favorites
- QM-0155900-01 Telcagepant [CAS 781649-09-0]
- QM-0154745-01 Thio-TEPA [CAS 52-24-4]
- QM-0061226 Uredepa [CAS 302-49-8]
- QM-0128544 Ubrogepant (Standard) [CAS 1374248-77-7]
- QM-0140930-01 Ubrogepant [CAS 1374248-77-7]
- QM-0144913-01 Vazegepant [CAS 1337918-83-8]
Vepafestinib [CAS 2129515-96-2]
Vepafestinib is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.